A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease (PADOVA): Rationale, Design, and Baseline Data-MedSci.cn

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease (PADOVA): Rationale, Design, and Baseline Data

Nikolcheva, T; Pagano, G; Pross, N; Simuni, T; Marek, K; Postuma, R; Pavese, N; Stocchi, F; Seppi, K; Monnet, A; Shariati, N; Rutten-Jacobs, L; Zanigni, S; Kustermann, T; Taylor, K; Trundell, D; Svoboda, H; Bonni, A; Fontoura, P; Doody, R

MOVEMENT DISORDERS, 2023; 38 (): S43

科室
- - 订阅+
  - 更多科室
工具
服务